Califf FDA commissioner nomination to go before Senate Health Committee Jan. 12
Win McNamee/Getty Images News


The Senate Committee on Health, Education, Labor, and Pension will meet on Jan. 12 to discuss the nomination of Robert Califf as FDA commissioner.
The hearing will be held in executive session and will not be webcast.

Califf has prior connections to the pharmaceutical industry. He has received consulting fees from companies including Merck (MRK
-0.4%), Amgen (AMGN
+0.5%), Biogen (BIIB
-1.7%), Roche (OTCQX:RHHBY
-2.3%) unit Genentech, and Eli Lilly (LLY
-2.2%).
During another confirmation hearing last month, Califf said that he supports prescription drug negotiation for Medicare, even though the FDA has no such authority in that area.
Dear Readers: We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion.